
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Pharmacol. , 22 March 2022
Sec. Translational Pharmacology
Volume 13 - 2022 | https://doi.org/10.3389/fphar.2022.851663
This article is part of the Research Topic Therapeutic Advances in Melatonin Research View all 7 articles
A retraction of this article was approved in:
Retraction: Melatonin mediates osteoblast proliferation through the STIM1/ORAI1 pathway
Citation: Cao L, Yang K, Yuan W, Zhou S, Zhao R and Qiu S (2022) Melatonin Mediates Osteoblast Proliferation Through the STIM1/ORAI1 Pathway. Front. Pharmacol. 13:851663. doi: 10.3389/fphar.2022.851663
Received: 10 January 2022; Accepted: 08 March 2022;
Published: 22 March 2022; Retracted: 28 September 2023.
Edited by:
Alejandro Romero, Complutense University of Madrid, SpainReviewed by:
Dun-Xian Tan, The University of Texas Health Science Center at San Antonio, United StatesDisclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.